(Q54239289)

26 May 2018

title

MYCN and survivin cooperatively contribute to malignant transformation of fibroblasts. (English)

1 reference

26 May 2018

author

Klaus-Michael Debatin

7

1 reference

26 May 2018

Stefan Walenta

5

object named as

Stefan Walenta

1 reference

26 May 2018

Wolfgang Müller-Klieser

4

object named as

Wolfgang Mueller-Klieser

1 reference

26 May 2018

author name string

Nora I Hipp

1

1 reference

26 May 2018

Lisa Christner

2

1 reference

26 May 2018

Thomas Wirth

3

1 reference

26 May 2018

Evelin Schröck

6

1 reference

26 May 2018

Christian Beltinger

8

1 reference

26 May 2018

language of work or name

English

0 references

publication date

15 October 2013

1 reference

26 May 2018

published in

Carcinogenesis

1 reference

26 May 2018

volume

35

1 reference

26 May 2018

issue

2

1 reference

26 May 2018

page(s)

479-488

1 reference

26 May 2018

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Pleiotropic role for MYCN in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Expression of MYCN in pediatric synovial sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Survivin is a negative prognostic marker in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

THE METABOLISM OF TUMORS IN THE BODY

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Metabolic reprogramming of the tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Neoplastic transformation by the human gene N-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Advances in sarcoma genomics and new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Rhabdomyosarcoma--working out the pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Altered growth and phenotype in clonal mycN transfectants of the SK-N-SH neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

The case for Survivin as mitotic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

The case for survivin as a regulator of microtubule dynamics and cell-death decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

IAP regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

The Polyoma virus 100K large T-antigen is not required for the maintenance of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

Transfer of a functional human immune system to mice with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT341

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGT341

1 reference

26 May 2018

1 reference

26 May 2018